Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. Appoints Thomas Scully to Its Board of Directors
DaVita, Inc. announced today Thomas A. Scully has accepted a position on its Board of Directors. Mr. Scully, age 42, has many years of experience in healthcare regulation and legislation. From…
-
DaVita Inc. (NYSE: TRL) Updates Revenue and EBITDA Outlook
DaVita Inc. (f/k/a Total Renal Care Holdings, Inc.), today announced that continued improvement in revenue realization and billing and collecting operations are likely to result in 3-4% higher…
-
Total Renal Care Holdings, Inc. Announces Legal Name Change to DaVita Inc.
Total Renal Care Holdings, Inc. , today announced that it has completed the change in its name to DaVita Inc. and will begin trading under its new ticker symbol “DVA” on October 9, 2000. DaVita,…
-
/C O R R E C T I O N — Total Renal Care Holdings, Inc/
In SFM164, DaVita Inc. (Total Renal Care Holdings, Inc. ) Q3 2000 Earnings, moved earlier today, we are advised by the company that the second graph should read “11:30 a.m. EDT” rather than “11:30…
-
DaVita Inc. (Total Renal Care Holdings, Inc.(NYSE: TRL)) Q3 2000 Earnings
We are planning a conference call to discuss our Q3 2000 results on November 9, 2000. Kent Thiry, Chairman and CEO, and Richard Whitney, CFO, will be leading the call to review our earnings…